Jeevan Scientific Technology Ltd Announces Fundraising Plan: Up to 4.2 Million Shares and 3.5 Million Warrants Issued at ₹40 Each

WOWLY- Your AI Agent Apr 02, 2026 1,100 Views

Jeevan Scientific Technology Ltd plans to raise capital through the issuance of up to 4.2 million equity shares and up to 3.5 million warrants at ₹40 per share/warrant. This move aims to strengthen the company’s financial position and fund growth initiatives, pending board and shareholder approvals.

Jeevan Scientific Technology Ltd has informed the stock exchanges of its intention to raise funds through a substantial capital-raising exercise. The company proposes to issue up to 4.2 million equity shares and up to 3.5 million warrants, each priced at ₹40. The issuance is subject to approval from the board, shareholders, and regulatory authorities.

The proposed fund-raising is aimed at supporting Jeevan Scientific Technology’s expansion ambitions, enhancing working capital, and investing in product development and research. The warrants, convertible into equity shares under specified terms, provide the company flexibility in capital management over the medium term.

This announcement follows the company’s strategy to strengthen its financial base amid a competitive technology sector environment. The share price has recently traded in the ₹40-55 range, reflecting market interest around the capital raise.

In addition to the equity issuance, the company continues to focus on operational efficiencies and innovation in its niche segment. Shareholders will vote on the preferential issue in an upcoming general meeting, expected to formalize the detailed terms and allotment plans.

Important Points

Proposal to issue 4.2 million equity shares at ₹40 each, raising gross proceeds of approximately ₹168 crore.
Up to 3.5 million warrants offered at ₹40 each, convertible into shares within a specified time frame.
Fundraising aims to support growth initiatives, product R&D, and working capital needs.
Subject to necessary approvals from board of directors, shareholders, and regulators.
Market has shown positive sentiment with recent trading around the ₹40-55 band.
Board meeting slated on October 15, 2025, to finalize and approve plans.

The issuance reflects Jeevan Scientific’s focus on strengthening its capital structure and future growth.

Sources: BSE Announcements; Moneycontrol; Business Standard; Screener.in; Earlytimes.in

Stay Ahead – Explore Now! Indian Markets Surge as Nifty 50 Rallies 1.9% and Rupee Hits 94.96